← SynDRA

RALIMETINIB

SynDRA canonical compound SYN0037191 — structure-anchored drug synonym record

All known targets

• MAPK14
• EGFR
• MAPK11

Mechanisms of action (all sources)

• MAPK14 INHIBITOR
• MAP kinase p38 alpha inhibitor
• EGFR INHIBITOR
• MAPK11 INHIBITOR

Cross-references

• PubChem CID: 11539025
• ChEMBL: CHEMBL2364626
• DrugBank: DB11787
• KEGG: D10658
• PDB: YXT
• Wikipedia: Ralimetinib
• TTD: D08WYH
• LINCS BRD: BRD-K59227464

Synonyms

• LY-2228820
• LSN-2322600 FREE BASE
• LSN2322600 FREE BASE
• LY2228820
• LY22288220
• LY-2228820 free base
• UNII-73I34XW4HD
• 73I34XW4HD
• 5-[2-(1,1-dimethylethyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)-3H-Imidazo[4,5-b]pyridin-2-amine
• C24H29FN6
• Ralimetinib [USAN:INN]
• LY2228820 free base
• Ralimetinib (USAN/INN)
• GTPL7959
• SCHEMBL3989306
• SCHEMBL13826263
• CHEMBL2364626
• DTXSID00235456
• MolPort-009-679-493
• XPPBBJCBDOEXDN-UHFFFAOYSA-N
• BCPP000180
• BCP02033
• ZINC34630490
• ABP000309
• 2526AH
• ABP000548
• AKOS027282678
• SB16635
• BCP9000871
• DB11787
• NCGC00346537-05
• LY-2180895
• LY-2211877
• LY-2228820 mesylate
• LY-2231377
• LY-2322600
• LY-479754
• LY-22288202MsOH
• P38 MAP kinase inhibitors (inflammation, cancer), Lilly